Fetal and Maternal Outcomes of Planned Pregnancy in Patients with Systemic Lupus Erythematosus: A Retrospective Multicenter Study

Table 3

Association of different characteristics during pregnancy with APOs: results of multivariate analysis.

Characteristics	value	OR	OR 95% CI
Fetal APOs
Composite APOs
Disease flares during pregnancy	<0.001	8.1	3.8–17.2
Anticardiolipin antibody positivity	<0.001	7.4	2.5–21.8
Fetal loss
Disease flares during pregnancy	0.002	28.4	3.4–239.0
Anticardiolipin antibody positivity	0.004	7.8	1.9–31.4
Preterm birth
Disease flares during pregnancy	0.002	3.5	1.6–7.7
PIH	<0.001	6.0	2.3–15.8
IUGR
PIH	<0.001	6.7	2.9–15.8
Fetal distress
PIH	<0.001	6.1	2.5–15.2
Maternal APOs
PIH
Disease flares during pregnancy	<0.001	12.2	4.4–33.3
Thrombocytopenia	0.04	4.0	1.1–14.8
aCL antibody positivity	<0.001	7.5	2.5–22.4